Drug Database
Back to search

Poland· PL-100472348

Brofestill

A bromfenac product containing bromfenacum, registered in Poland by Pharm Supply Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.

ATC S01BC11

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBrofestillATCS01BC11REGISTER NO.PL-100472348PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bromfenacumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bromfenac is registered in 15 of 19 countries.

Countries holding a registration under ATC S01BC11 (bromfenac), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search bromfenac products by name

Bromfenac · ATC S01BC11

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Bromfenacum
Manufacturer
Pharm Supply Sp. z o.o.
Country
Poland (PL)
ATC code
S01BC11
ATC class
Bromfenac
Defined daily dose
66 mcg, AT
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991552220
  • gtin
    05909991552190
  • gtin
    05909991552206
  • gtin
    05909991552213

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

200 interactions on record for bromfenac.

Graded by severity as the source publishes them — 53 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check bromfenac against other medicinesHow interaction checks work

Bromfenac · interactions on record

200 records

  • 53 severe
  • 145 moderate
  • 2 minor

Most severe, free to view

  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • PrasugrelB01AC22severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bromfenac in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bromfenac products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Cyprus · Eyebrom
  • Czechia · Bromfenac Olikla
  • Spain · Alcarix, Eyebrom
  • Finland · Bromfenac
  • United Kingdom (Northern Ireland) · Bromfenac Aspire Pharma, Yellox
  • Greece · Eyebrom
  • Iceland · Yellox
  • Italy · Bromoftil, Coxafen
  • Liechtenstein · Yellox
  • Netherlands · Bromfenac, Broomfenac Ntc
  • Norway · Bromfenac Blumont, Yellox
  • Portugal · Brovit, Katlox
  • Slovakia · Bromfenac Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aed3bfcf-4785-41f5-984d-e7f75780af01
GET /v1/drugs/aed3bfcf-4785-41f5-984d-e7f75780af01?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople do oczu, roztwór w pojemniku jednodawkowym",
  "source": "urpl",
  "strength": "0,9 mg/ml",
  "packaging": "05909991552220 ¦ Rp ¦ 157453\n30 poj. jednodawkowych 0,25 ml\n05909991552190 ¦ Rp ¦ 157454\n10 poj. jednodawkowych 0,25 ml\n05909991552206 ¦ Rp ¦ 157455\n20 poj. jednodawkowych 0,25 ml\n05909991552213 ¦ Rp ¦ 157456\n5 poj. jednodawkowych 0,25 ml",
  "substance": "Bromfenacum 0.9 mg/ml",
  "common_name": "Bromfenacum",
  "pl_product_id": "100472348",
  "pozwolenie_nr": "28535",
  "auth_procedure": "NAR",
  "authorisation_validity": "2029-07-30"
}
API referenceMCP serverPlans

See everything about bromfenac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console